Baebies

Baebies

Baebies develops and commercializes products and services that enable early disease detection and comprehensive diagnosis. The company’s products are powered by digital microfluidics (DMF), an innovative technology to electronically manipulate microliter-sized drops of liquid. Baebies miniaturizes conventional diagnosti ...

Recently updated

Near-Patient Testing Platform
FINDER

FINDER is a near-patient testing platform powered by digital microfluidics that is specifically designed to address the need for tests requiring low blood volume - with a turnaround time of approximately 15 minutes after sample introduction. The innovative platform operates on 50 microliters of blood for testing and is just 8 inches wide and comes with a tablet for user interface, making it ideal for use in various settings.
More details

Newborn Screening Lab Solution
SEEKER

SEEKER is a newborn screening laboratory solution that performs multiple assays at the same time using just one punch from a newborn dried blood spot specimen. SEEKER is the first FDA-authorized and CE-marked newborn screening platform for lysosomal storage disorders (LSD) and quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens.
More details

Clinical Laboratory

Near-Patient Testing Platform
FINDER

FINDER is a near-patient testing platform powered by digital microfluidics that is specifically designed to address the need for tests requiring low blood volume - with a turnaround time of approximately 15 minutes after sample introduction. The innovative platform operates on 50 microliters of blood for testing and is just 8 inches wide and comes with a tablet for user interface, making it ideal for use in various settings.
More details

Newborn Screening Lab Solution
SEEKER

SEEKER is a newborn screening laboratory solution that performs multiple assays at the same time using just one punch from a newborn dried blood spot specimen. SEEKER is the first FDA-authorized and CE-marked newborn screening platform for lysosomal storage disorders (LSD) and quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens.
More details

Point-Of-Care Testing

Near-Patient Testing Platform
FINDER

FINDER is a near-patient testing platform powered by digital microfluidics that is specifically designed to address the need for tests requiring low blood volume - with a turnaround time of approximately 15 minutes after sample introduction. The innovative platform operates on 50 microliters of blood for testing and is just 8 inches wide and comes with a tablet for user interface, making it ideal for use in various settings.
More details
Copyright © 2000-2026 TradeMed.com. All rights reserved. | Terms And Conditions